Loading...
•
Sep 30, 2021
Zimmer Biomet Q3 2021 Earnings Report
Reported a decrease in net sales and updated 2021 financial guidance.
Key Takeaways
Zimmer Biomet reported third quarter net sales of $1.924 billion, a decrease of 0.3% from the prior year period. Diluted earnings per share were $0.69 for the third quarter, and adjusted diluted earnings per share were $1.81. The company updated its full-year 2021 financial guidance, reducing and narrowing its previous projected ranges for revenue growth, adjusted operating profit margin and adjusted diluted EPS.
Third quarter net sales of $1.924 billion decreased 0.3% and 0.8% on a constant currency basis.
Third quarter diluted earnings per share were $0.69; adjusted diluted earnings per share were $1.81.
Third quarter 2021 net sales increased 1.7% when compared to the pre-pandemic third quarter 2019, and increased 0.4% on a constant currency basis.
Company updates 2021 financial guidance, reducing and narrowing range for full year outlook
Zimmer Biomet
Zimmer Biomet
Zimmer Biomet Revenue by Segment
Zimmer Biomet Revenue by Geographic Location
Revenue by Segment
Knees Revenue
CapyFin.comHips Revenue
CapyFin.comS.E.T. Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The Company is updating its full-year 2021 financial guidance to reduce and narrow its previous projected ranges for revenue growth, adjusted operating profit margin and adjusted diluted EPS.
Revenue & Expenses
Visualization of income flow from segment revenue to net income